Kamiya K, Kodama I, Toyama J
Department of Circulation and Respiration, Research Institute of Environmental Medicine, Nagoya University, Japan.
Cardiovasc Res. 1991 Jun;25(6):516-22. doi: 10.1093/cvr/25.6.516.
The aim was to study an interaction between class I antiarrhythmic drugs on the cardiac sodium channels.
The single pipette, whole cell clamp method was employed to control and record membrane potential. The maximum upstroke velocity (dV/dtmax) was measured as an index of sodium channel availability during treatment of the preparations with aprindine (5 microM) in combination with mexiletine (40 microM), and lignocaine (40 microM).
Single ventricular myocytes (n = 6-8 per experiment) isolated from guinea pig hearts were used.
Trains of depolarisation to 0 mV (0.2-2.0 Hz) were applied from the resting membrane potential (-85 mV) following a long quiescent period to evaluate "tonic" and "use dependent" decrease (block) of dV/dtmax. Additional application of mexiletine or lignocaine to aprindine resulted in an increase of tonic block and a decrease of use dependent block. Because of such counteracting action, the steady state dV/dtmax during the train of depolarisation was unaffected for mexiletine, and even increased for lignocaine. Dual exponential components of dV/dtmax recovery following a 1 s conditioning depolarisation after admixture of mexiletine or lignocaine to aprindine suggest their competitive interaction on cardiac sodium channels.
A combination of class I antiarrhythmic drugs having high affinity for the inactivated state of sodium channels may cause a reductive effect on dV/dtmax through competitive displacement from common receptors.
旨在研究I类抗心律失常药物对心脏钠通道的相互作用。
采用单吸管全细胞钳制方法来控制和记录膜电位。在使用阿普林定(5微摩尔)联合美西律(40微摩尔)和利多卡因(40微摩尔)处理标本期间,测量最大除极速度(dV/dtmax)作为钠通道可用性的指标。
使用从豚鼠心脏分离的单个心室肌细胞(每个实验n = 6 - 8)。
在长时间静息期后,从静息膜电位(-85毫伏)施加到0毫伏(0.2 - 2.0赫兹)的去极化脉冲串,以评估dV/dtmax的“强直”和“使用依赖性”降低(阻滞)。在阿普林定基础上额外应用美西律或利多卡因导致强直阻滞增加,使用依赖性阻滞降低。由于这种抵消作用,去极化脉冲串期间的稳态dV/dtmax对于美西律不受影响,而对于利多卡因甚至增加。在阿普林定中加入美西律或利多卡因后,1秒条件性去极化后dV/dtmax恢复的双指数成分表明它们在心脏钠通道上存在竞争性相互作用。
对钠通道失活状态具有高亲和力的I类抗心律失常药物联合使用可能通过从共同受体上竞争性置换而对dV/dtmax产生降低作用。